Subsequently, consistent studies have reported that GPD1 expression is significantly reduced in several other cancers, such as breast, lung, bladder, and kidney cancer, and that a low expression level of GPD1 is significantly correlated with a poor survival rate17,132,133. This evidence concerns the gene GPD1 and cancer.